Patent US5994341A successfully refreshed from Google Patents.
US5994341A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Anti-angiogenic Compositions and methods for the treatment of arthritis
Assignee: Angiotech Pharmaceuticals Inc
•
Filing: 1995-06-07
•
Granted: 1999-11-30
•
Expires: 2015-06-07
Abstract
Abstract The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.
Inventors
- 👤 William L. Hunter
- 👤 Lindsay S. Machan
- 👤 A. Larry Arsenault
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-30 02:26
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/14; A61K9/16; A61K9/1605; A61K9/1629; A61K9/1635; A61K31/00; A61K31/12; A61K31/122; A61K31/13; A61K31/135; A61K31/136; A61K31/185; A61K31/19; A61K31/20; A61K31/203; A61K31/33; A61K31/335; A61K31/337; A61K31/395; A61K31/495; A61K31/505; A61K31/519; A61K31/56; A61K31/57; A61K33/00; A61K33/24; A61K38/00; A61K38/16; A61K38/55; A61K38/57; A61K45/00; A61K45/06; A61K47/00; A61K47/50; A61K47/69; A61K47/6921; A61K47/6927; A61K47/6957; A61K9/1641; A61K9/1647; A61K9/1658; A61K9/167; A61K9/48; A61K9/50; A61K9/51; A61K9/5107; A61K9/513; A61K9/5146; A61K9/5153; A61K9/5161; A61K9/5169; A61K9/70; A61K9/7007; A61L; A61L31/00; A61L31/08; A61L31/10; A61L31/14; A61L31/145; A61L31/16; C; C07; C07K; C07K14/00; C07K14/81; C07K14/8107; C07K14/811; A61L2300/00; A61L2300/40; A61L2300/416; A61L2300/60; A61L2300/606; A61L2300/62; A61L2300/622; C08; C08L; C08L2203/00; C08L2203/02; C08L23/00; C08L23/02; C08L23/04; C08L23/08; C08L23/0846; C08L23/0853; C08L2312/00
Claims Analysis
Total Claims: 10
Claim 1
Independent Claim
30 words
A method for treating inflammatory arthritis, comprising directly administering to a joint of a patient a therapeutically effective amount of a composition comprising paclitaxel, or an analogue or derivative thereof.
Claim 2
Independent Claim
30 words
A method for treating inflammatory arthritis, comprising directly administering to a joint of a patient a therapeutically effective amount of a composition comprising paclitaxel, or an analogue or derivative thereof.
Claim 3
Independent Claim
29 words
A method for treating osteoarthritis, comprising directly administering to a joint of a patient a therapeutically effective amount of a composition comprising paclitaxel, or an analogue or derivative thereof.
Claim 4
Independent Claim
29 words
A method for treating osteoarthritis, comprising directly administering to a joint of a patient a therapeutically effective amount of a composition comprising paclitaxel, or an analogue or derivative thereof.
Claim 5
Independent Claim
18 words
The method according to any one of claims 1 or 2 wherein said composition further comprises a polymer.
Claim 6
Dependent Claim
11 words
The method according to claim 3 wherein said polymer comprises poly(caprolactone).
Claim 7
Dependent Claim
12 words
The method according to claim 3 wherein said polymer comprises poly(lactic acid).
Claim 8
Dependent Claim
12 words
The method according to claim 3 wherein said polymer comprises poly(ethylene-vinyl acetate).
Claim 9
Dependent Claim
12 words
The method according to claim 3 wherein said polymeric comprises poly(lactic-co-glycolic) acid.
Claim 10
Dependent Claim
13 words
The method according to claim 1 wherein said inflammatory arthritis is rheumatoid arthritis.
References Cited (Backward Citations)
US4542025A
Cited
EP0375520A1
Cited
US5039521A
Cited
US5061724A
Cited
WO1991010424A1
Cited
WO1991011193A1
Cited
EP0470569A1
Cited
WO1992012717A2
Cited
WO1992015286A1
Cited
US5511563A
Cited
EP0567816A1
Cited
US5530003A
Cited
WO1995003036A1
Cited
US5529786A
Cited
US5583153A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2002-11-29 | 2003-05-31 | 2003-11-30 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2006-11-29 | 2007-05-31 | 2007-11-30 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2010-11-29 | 2011-05-31 | 2011-11-30 | $7700.00 | Window Closed / Lapsed |